Cite
miR-145 suppresses ovarian cancer progression via modulation of cell growth and invasion by targeting CCND2 and E2F3.
MLA
Hua, Minhui, et al. “MiR-145 Suppresses Ovarian Cancer Progression via Modulation of Cell Growth and Invasion by Targeting CCND2 and E2F3.” Molecular Medicine Reports, vol. 19, no. 5, May 2019, pp. 3575–83. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=135966817&authtype=sso&custid=ns315887.
APA
Hua, M., Qin, Y., Sheng, M., Cui, X., Chen, W., Zhong, J., Yan, J., & Chen, Y. (2019). miR-145 suppresses ovarian cancer progression via modulation of cell growth and invasion by targeting CCND2 and E2F3. Molecular Medicine Reports, 19(5), 3575–3583.
Chicago
Hua, Minhui, Yongwei Qin, Meihong Sheng, Xiaopeng Cui, Weiguan Chen, Jianxin Zhong, Junming Yan, and Yan Chen. 2019. “MiR-145 Suppresses Ovarian Cancer Progression via Modulation of Cell Growth and Invasion by Targeting CCND2 and E2F3.” Molecular Medicine Reports 19 (5): 3575–83. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=135966817&authtype=sso&custid=ns315887.